These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 24414069)
1. Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. Vimercati C; Qanud K; Mitacchione G; Sosnowska D; Ungvari Z; Sarnari R; Mania D; Patel N; Hintze TH; Gupte SA; Stanley WC; Recchia FA Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H709-17. PubMed ID: 24414069 [TBL] [Abstract][Full Text] [Related]
2. The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure. Badolia R; Ramadurai DKA; Abel ED; Ferrin P; Taleb I; Shankar TS; Krokidi AT; Navankasattusas S; McKellar SH; Yin M; Kfoury AG; Wever-Pinzon O; Fang JC; Selzman CH; Chaudhuri D; Rutter J; Drakos SG Circulation; 2020 Jul; 142(3):259-274. PubMed ID: 32351122 [TBL] [Abstract][Full Text] [Related]
3. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Ekelund UE; Harrison RW; Shokek O; Thakkar RN; Tunin RS; Senzaki H; Kass DA; Marbán E; Hare JM Circ Res; 1999 Sep; 85(5):437-45. PubMed ID: 10473673 [TBL] [Abstract][Full Text] [Related]
4. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. Gupte SA; Levine RJ; Gupte RS; Young ME; Lionetti V; Labinskyy V; Floyd BC; Ojaimi C; Bellomo M; Wolin MS; Recchia FA J Mol Cell Cardiol; 2006 Aug; 41(2):340-9. PubMed ID: 16828794 [TBL] [Abstract][Full Text] [Related]
5. CVT-4325 inhibits myocardial fatty acid uptake and improves left ventricular systolic function without increasing myocardial oxygen consumption in dogs with chronic heart failure. Imai M; Rastogi S; Sharma N; Chandler MP; Sharov VG; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN Cardiovasc Drugs Ther; 2007 Feb; 21(1):9-15. PubMed ID: 17119875 [TBL] [Abstract][Full Text] [Related]
6. Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure. Qanud K; Mamdani M; Pepe M; Khairallah RJ; Gravel J; Lei B; Gupte SA; Sharov VG; Sabbah HN; Stanley WC; Recchia FA Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2098-105. PubMed ID: 18820029 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the pentose phosphate pathway decreases ischemia-reperfusion-induced creatine kinase release in the heart. Zuurbier CJ; Eerbeek O; Goedhart PT; Struys EA; Verhoeven NM; Jakobs C; Ince C Cardiovasc Res; 2004 Apr; 62(1):145-53. PubMed ID: 15023561 [TBL] [Abstract][Full Text] [Related]
8. Monitoring flux through the oxidative pentose phosphate pathway using [1-14C]gluconate. Garlick AP; Moore C; Kruger NJ Planta; 2002 Dec; 216(2):265-72. PubMed ID: 12447540 [TBL] [Abstract][Full Text] [Related]
9. Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure. Li X; Lu Q; Qiu Y; do Carmo JM; Wang Z; da Silva AA; Mouton A; Omoto ACM; Hall ME; Li J; Hall JE J Am Heart Assoc; 2021 Mar; 10(6):e018298. PubMed ID: 33719499 [TBL] [Abstract][Full Text] [Related]
10. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine. El Alaoui-Talibi Z; Guendouz A; Moravec M; Moravec J Am J Physiol; 1997 Apr; 272(4 Pt 2):H1615-24. PubMed ID: 9139943 [TBL] [Abstract][Full Text] [Related]